Literature DB >> 21953415

Update: peripheral T-cell lymphomas.

Kerry J Savage1.   

Abstract

Peripheral T-cell lymphomas (PTCLs) are a group of biologically heterogeneous but typically aggressive diseases. Progress in understanding and developing optimal therapies for PTCLs has been hampered by disease rarity and only relatively recent recognition of the importance of the T-cell phenotype. The International Peripheral T-cell Lymphoma Project was a large collaborative effort to provide a broader understanding of prognosis. Recently, several new therapies have shown promise in the treatment of PTCLs.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21953415     DOI： 10.1007/s11899-011-0100-3

Source DB:  PubMed          Journal:  Curr Hematol Malig Rep        ISSN： 1558-8211            Impact factor:   3.952


  45 in total

1.  Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing.

Authors:  Andrew L Feldman; Ahmet Dogan; David I Smith; Mark E Law; Stephen M Ansell; Sarah H Johnson; Julie C Porcher; Nazan Ozsan; Eric D Wieben; Bruce W Eckloff; George Vasmatzis
Journal:  Blood       Date:  2010-10-28       Impact factor: 22.113

2.  Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma.

Authors:  R I Fisher; E R Gaynor; S Dahlberg; M M Oken; T M Grogan; E M Mize; J H Glick; C A Coltman; T P Miller
Journal:  N Engl J Med       Date:  1993-04-08       Impact factor: 91.245

3.  Prognostic significance of CD56 expression for ALK-positive and ALK-negative anaplastic large-cell lymphoma of T/null cell phenotype.

Authors:  R Suzuki; Y Kagami; K Takeuchi; M Kami; M Okamoto; R Ichinohasama; N Mori; M Kojima; T Yoshino; H Yamabe; M Shiota; S Mori; M Ogura; N Hamajima; M Seto; T Suchi; Y Morishima; S Nakamura
Journal:  Blood       Date:  2000-11-01       Impact factor: 22.113

4.  Primary anaplastic large-cell lymphoma associated with breast implants.

Authors:  Leslie Popplewell; Sandra H Thomas; Qin Huang; Karen L Chang; Stephen J Forman
Journal:  Leuk Lymphoma       Date:  2011-06-24

5.  Identification of differential and functionally active miRNAs in both anaplastic lymphoma kinase (ALK)+ and ALK- anaplastic large-cell lymphoma.

Authors:  Olaf Merkel; Frank Hamacher; Daniela Laimer; Eveline Sifft; Zlatko Trajanoski; Marcel Scheideler; Gerda Egger; Melanie R Hassler; Christiane Thallinger; Ana Schmatz; Suzanne D Turner; Richard Greil; Lukas Kenner
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-30       Impact factor: 11.205

6.  Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group.

Authors:  Norbert Schmitz; Lorenz Trümper; Marita Ziepert; Maike Nickelsen; Anthony D Ho; Bernd Metzner; Norma Peter; Markus Loeffler; Andreas Rosenwald; Michael Pfreundschuh
Journal:  Blood       Date:  2010-07-21       Impact factor: 22.113

7.  Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials.

Authors:  Nathalie Mourad; Nicolas Mounier; Josette Brière; Emmanuel Raffoux; Alain Delmer; Alfred Feller; Chris J L M Meijer; Jean-François Emile; Réda Bouabdallah; André Bosly; Jacques Diebold; Corinne Haioun; Bertrand Coiffier; Christian Gisselbrecht; Philippe Gaulard
Journal:  Blood       Date:  2008-02-21       Impact factor: 22.113

8.  The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells.

Authors:  Laurence de Leval; David S Rickman; Caroline Thielen; Aurélien de Reynies; Yen-Lin Huang; Georges Delsol; Laurence Lamant; Karen Leroy; Josette Brière; Thierry Molina; Françoise Berger; Christian Gisselbrecht; Luc Xerri; Philippe Gaulard
Journal:  Blood       Date:  2007-02-06       Impact factor: 22.113

9.  Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma.

Authors:  S W Morris; M N Kirstein; M B Valentine; K G Dittmer; D N Shapiro; D L Saltman; A T Look
Journal:  Science       Date:  1994-03-04       Impact factor: 47.728

10.  Impact of autologous and allogeneic stem cell transplantation in peripheral T-cell lymphomas.

Authors:  Peter Reimer
Journal:  Adv Hematol       Date:  2010-12-21
View more
  7 in total

1.  The oncogenic transcription factor IRF4 is regulated by a novel CD30/NF-κB positive feedback loop in peripheral T-cell lymphoma.

Authors:  Rebecca L Boddicker; N Sertac Kip; Xiaoming Xing; Yu Zeng; Zhi-Zhang Yang; Jeong-Heon Lee; Luciana L Almada; Sherine F Elsawa; Ryan A Knudson; Mark E Law; Rhett P Ketterling; Julie M Cunningham; Yanhong Wu; Matthew J Maurer; Megan M O'Byrne; James R Cerhan; Susan L Slager; Brian K Link; Julie C Porcher; Deanna M Grote; Diane F Jelinek; Ahmet Dogan; Stephen M Ansell; Martin E Fernandez-Zapico; Andrew L Feldman
Journal:  Blood       Date:  2015-04-01       Impact factor: 22.113

2.  A retrospective clinical analysis of Japanese patients with peripheral T-cell lymphoma not otherwise specified: Hokkaido Hematology Study Group.

Authors:  Yoshihiro Torimoto; Kazuya Sato; Katsuya Ikuta; Toshiaki Hayashi; Yasuo Hirayama; Junki Inamura; Hajime Kobayashi; Ryoji Kobayashi; Kyuhei Koda; Mitsutoshi Kurosawa; Akio Mori; Shuichi Ota; Hajime Sakai; Akio Shigematsu; Motohiro Shindo; Hitoshi Shinzaki; Fumihiko Takahashi; Rishu Takimoto; Junji Tanaka; Satoshi Yamamoto; Yutaka Kohgo; Takashi Fukuhara
Journal:  Int J Hematol       Date:  2013-06-29       Impact factor: 2.490

3.  Concurrent Mutations in ATM and Genes Associated with Common γ Chain Signaling in Peripheral T Cell Lymphoma.

Authors:  Haley M Simpson; Rashid Z Khan; Chang Song; Deva Sharma; Kavitha Sadashivaiah; Aki Furusawa; Xinyue Liu; Sushma Nagaraj; Naomi Sengamalay; Lisa Sadzewicz; Luke J Tallon; Qing C Chen; Ferenc Livak; Aaron P Rapoport; Amy Kimball; Arnob Banerjee
Journal:  PLoS One       Date:  2015-11-04       Impact factor: 3.240

4.  IRF4/MUM1 expression is associated with poor survival outcomes in patients with peripheral T-cell lymphoma.

Authors:  Mi Hwa Heo; Ha Young Park; Young Hyeh Ko; Won Seog Kim; Seok Jin Kim
Journal:  J Cancer       Date:  2017-03-29       Impact factor: 4.207

5.  STAT5 inhibition induces TRAIL/DR4 dependent apoptosis in peripheral T-cell lymphoma.

Authors:  Haley M Simpson; Aki Furusawa; Kavitha Sadashivaiah; Curt I Civin; Arnob Banerjee
Journal:  Oncotarget       Date:  2018-03-30

6.  Cluster Containing More Than 20 CD3-Positive Cells in Bone Marrow Biopsy Is a Candidate Prognostic Indicator in Peripheral T-Cell Lymphoma, Not Otherwise Specified.

Authors:  Hyoeun Shim; Seongsoo Jang; Jooryung Huh; Dok Hyun Yoon; Cheolwon Suh; Chan Jeoung Park
Journal:  Ann Lab Med       Date:  2019-03       Impact factor: 3.464

7.  CHO(E)P-14 followed by alemtuzumab consolidation in untreated peripheral T cell lymphomas: final analysis of a prospective phase II trial.

Authors:  C Binder; M Ziepert; M Pfreundschuh; U Dührsen; H Eimermacher; A Aldaoud; A Rosenwald; M Loeffler; N Schmitz; L Truemper
Journal:  Ann Hematol       Date:  2013-08-24       Impact factor: 3.673
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.